INIFY Laboratories AB (OSL:INIFY)
Norway · Delayed Price · Currency is NOK 5.30
0.00 (0.00%)
At close: Sep 9, 2025
INIFY Laboratories AB Market Cap
INIFY Laboratories AB has a market cap or net worth of 461.58 million as of September 12, 2025. Its market cap has increased by 33.38% in one year.
Market Cap
461.58M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5.30
Market Cap Chart
Since June 20, 2022, INIFY Laboratories AB's market cap has increased from 452.37M to 461.58M, an increase of 2.04%. That is a compound annual growth rate of 0.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 461.58M | 22.37% |
| Dec 30, 2024 | 377.20M | -32.76% |
| Dec 29, 2023 | 560.94M | 72.20% |
| Dec 30, 2022 | 325.75M | -27.99% |
| Jun 20, 2022 | 452.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.50B |
| Nordhealth AS | 2.85B |
| Photocure ASA | 1.62B |
| Thor Medical ASA | 1.40B |
| ArcticZymes Technologies ASA | 1.37B |
| Vistin Pharma ASA | 1.03B |
| Omda AS | 990.52M |
| Gentian Diagnostics ASA | 869.82M |